Purdue Gets OK For $6.5M Investment In Overdose Drug

By Rick Archer · June 23, 2020, 4:19 PM EDT

A New York bankruptcy judge gave Purdue Pharma permission Tuesday to invest $6.5 million in a company working on an over-the-counter opioid-overdose drug, saying that keeping the development effort going was an...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

Purdue Pharma L.P.

Case Number

Court

New York Southern

Nature of Suit

Date Filed

September 15, 2019

Recent Articles By Rick

October 01, 2024
Nostrum Labs Hits Ch. 11 A Year After Medicaid Settlement
June 27, 2024
Insurers Call Rite Aid Ch. 11 Opioid Deal Unfair
June 03, 2024
Judge Says It's Time For DIP Deal For Steward Healthcare
May 28, 2024
Medical Test Maker To Liquidate After FDA Slams COVID Kits
May 17, 2024
Cano Health Strikes $7M Deal With Unsecured Creditors
May 07, 2024
Steward Health Gets Ch. 11 Loan, Says It Plans Hospital Sales
May 06, 2024
Hospital Chain Steward Health Hits Ch. 11 With Over $1B Debt
May 03, 2024
Acorda Therapeutics Strikes Creditor Deal On Ch. 11 Loan
May 02, 2024
Skin Care Drug Co. Gets OK For Ch. 11 Wind-Down Plan
March 19, 2024
Skin Care Drug Co. Can Ask Creditors To OK Ch. 11 Plan